Healthestate, LLC v. United States

United States Court of Federal Claims·Decided October 27, 2021·No. 18-34·Unpublished

Opinion

IN THE UNITED STATES COURT OF FEDERAL CLAIMS )

HEALTHESTATE LLC, )

)

Plaintiff, )

) No. 1:18-cv-34C v. ) (Judge Davis)

)

THE UNITED STATES, ) Filed: October 7, 2021 )

Defendant, ) Reissued: October 27, 2021 )

and )

)

ASM RESEARCH LLC, )

)

Third-Party Defendant. )

)

MEMORANDUM OPINION AND ORDER On August 3, 2021, Third-Party Defendant ASM Research LLC (“ASM”) filed a Motion for Leave to File an Amended Answer pursuant to Rule 15(a)(2) of the Rules of the United States Court of Federal Claims (“RCFC”), seeking to add an affirmative defense under 17 U.S.C § 117(a). Plaintiff HEALTHeSTATE, LLC (“HeS”) opposes, arguing that the amendment would, among other things, be unduly prejudicial and futile. For the reasons discussed below, ASM’s motion is GRANTED.

I. BACKGROUND

HeS filed this action in January 2018, asserting a copyright infringement claim related to the alleged unlicensed use of its software code by the Government and ASM. See Pl.’s Compl., ECF No. 1. It filed an Amended Complaint in March 2018. See ECF No. 6. After the Government unsuccessfully moved to dismiss the Amended Complaint, the Court granted the Government’s motion to notify ASM of its interest in this action. See Order, ECF No. 27; Def.’s Unopposed Mot. for R. 14(b) Notice to ASM, ECF No. 28; Order, ECF No. 30. The Government served ASM

with a Rule 14 Notice in August 2019, and ASM filed its responsive pleading—a motion to dismiss the Amended Complaint—in October 2019. See Def.’s Return of Service of R. 14(b) Notice to ASM, ECF No. 33; Mot. to Dismiss Filed by ASM, ECF No. 37. The Court stayed discovery pending resolution of ASM’s motion. Order at 4, ECF No. 43. On January 31, 2020, the Court denied that motion. Mem. Op. and Order at 2, ECF No. 51. ASM filed its Answer on February 14, 2020. See ECF No. 52. The Court continued the stay of discovery while Defendants jointly sought reconsideration of the order denying ASM’s motion to dismiss and, thereafter, while ASM pursued an interlocutory appeal. Order at 1, ECF No. 60; Order, ECF No. 75. ASM’s appeal was denied in September 2020, and the Court subsequently entered a discovery scheduling order in October 2020. Joint Status Report at 1, ECF No. 76; see Order, ECF No. 83. Per the scheduling order, fact discovery was set to close on June 21, 2021. ECF No. 83 at 1. On May 6, 2021, the Court granted HeS’s and the Government’s unopposed joint motion to extend fact discovery by an additional 16 weeks. Order at 1, ECF No. 105. The Court recently further extended that deadline, at HeS’s request, to December 1, 2021. Order at 2, ECF No. 118.

On October 30, 2020, ASM served HeS with its first set of interrogatories. See ASM’s Opposed Mot. for Leave to File Am. Answer at 7, ECF No. 106. Interrogatory No. 1 asked HeS, “[f]or each HeS Software, [to] [i]dentify and describe the HeS Software in detail,” including information regarding specification, functionality, versions, differences, and whether the software is the “HeS baseline software” at issue in this case. Pl.’s Second Suppl. Objs. and Answers to ASM’s First Set of Interrogs. to Pl. at 5, ECF No. 106-2. HeS’s original response was essentially non-responsive. See id. Its first supplemental response, provided in January 2021, stated that the “Source Code produced to ASM on January 15, 2021 . . . is the baseline code,” and it referred ASM to documents produced on a Google Drive. Id. After ASM moved to compel more specific

interrogatory responses, the Court directed the parties to meet and confer to resolve outstanding disputes. See ASM’s Mot. to Compel, ECF No. 86; Order, ECF No. 94. As a result of those efforts, HeS provided a second supplemental response to Interrogatory No. 1 in April 2021, stating that “‘HeS’s underlying source code’ . . . is HEALTHeSTATE EHR Release 5.2 Iteration 11.” ECF No. 106-2 at 6. HeS further stated that “[a]ll software contemplated in this suit are either duplicates or derivative works of HEALTHeSTATE EHR Release 5.2 Iteration 11.” Id. at 7.

On July 15, 2021, ASM notified HeS and the Government of its intent to amend its Answer to add an affirmative defense under 17 U.S.C. § 117(a).1 See ECF No. 106 at 9. ASM’s proposed affirmative defense would assert that the United States is the owner of a copy of the software code at issue, that it is entitled under § 117(a) to make or authorize the making of copies or adaptions of such copyrighted work, and that the allegedly infringing conduct at issue meets the requirements in § 117(a) such that there is no liability for ASM’s alleged infringement. Id. at 5. The Government consented to ASM’s amendment request, but HeS indicated its opposition. Id. at 9. ASM filed the instant motion to amend on August 3, 2021. See id. The motion is now fully briefed.

II. DISCUSSION

Under RCFC 8, a defendant is obligated to set forth its affirmative defenses in its responsive pleading. See RCFC 8(c). RCFC 15 allows a defendant to amend its responsive pleading either by the written consent of the opposing party or by leave of the Court. See RCFC 15(a)(2). The Court should “liberally” exercise its discretion and grant leave to amend, absent a

1This provision states that “it is not an infringement for the owner of a copy of a computer program to make or authorize the making of another copy or adaptation of that computer program provided . . . that such a new copy or adaptation is created as an essential step in the utilization of the computer program in conjunction with a machine and that it is used in no other manner. . . .” 17 U.S.C. § 117(a).

showing of undue delay, bad faith or dilatory motive by the movant, repeated failures to cure deficiencies by previous amendments, undue prejudice on the nonmovant by allowing the amendment, or futility. Mitsui Foods, Inc. v. United States, 867 F.2d 1401, 1403–04 (Fed. Cir. 1989) (citing Foman v. Davis, 371 U.S. 178, 182 (1962)); see RCFC 15(a)(2) (“The court should freely give leave when justice so requires.”).

ASM argues that its motion is timely, having been filed a little over three months after HeS served its second supplemental responses specifically identifying the facts that give rise to the instant motion. ECF No. 106 at 11. It further argues that granting the motion will not unduly prejudice HeS, as discovery is still open and no dispositive motions have been filed. Id. at 10–11. It also argues that no other reason—like bad faith or delay—warrants denying the motion. Id. at 13. HeS argues, on the contrary, that ASM’s motion is untimely because ASM possessed sufficient information to assess its defenses in January 2021—seven months before moving for leave to amend. Pl.’s Opp’n to ASM’s Mot. for Leave at 14–15, ECF No. 107. It contends that amendment will cause undue prejudice because it will require HeS to conduct additional discovery. Id. at 17. HeS also asserts that amendment is futile because the Government cannot reasonably claim ownership over the source code or any copies. Id. at 20. Having considered the parties’ arguments, the Court finds that permitting ASM leave to amend its Answer is appropriate.

A. ASM’s Motion Is Timely.

The Court first looks to the timeliness of ASM’s proposed amendment. HeS argues that ASM failed to act promptly because HeS’s first supplemental response to ASM’s Interrogatory No. 1 informed ASM of the information relevant to the proposed amendment as early as January 15, 2021. ECF No. 107 at 14–15. ASM disputes this, arguing that April 14, 2021, is the relevant date because that is when HeS identified in its second supplemental response that the software at

issue is Release 5.2 Iteration 11. ASM’s Reply in Support of Mot. for Leave to File Am. Answer at 10, ECF No. 108; ECF No. 106 at 8. Regardless of which date the Court uses (either January or April 2021), the amendment request is timely.

Free access — add to your briefcase to read the full text and ask questions with AI

Healthestate, LLC v. United States, (uscfc 2021).

Healthestate, LLC v. United States (Healthestate, LLC v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Mitsui Foods, Inc. v. The United States
867 F.2d 1401 (Federal Circuit, 1989)
Cencast Services, L.P. v. United States
729 F.3d 1352 (Federal Circuit, 2013)
Katzin v. United States
115 Fed. Cl. 618 (Federal Claims, 2014)
King v. United States
119 Fed. Cl. 51 (Federal Claims, 2014)
Alta Wind I Owner Lessor C v. United States
125 Fed. Cl. 8 (Federal Claims, 2016)
Hanover Insurance Company (The) v. United States
134 Fed. Cl. 51 (Federal Claims, 2017)
St. Paul Fire & Marine Insurance v. United States
39 Cont. Cas. Fed. 76,666 (Federal Claims, 1994)
Cooke v. United States
79 Fed. Cl. 741 (Federal Claims, 2007)
Alaska v. United States
15 Cl. Ct. 276 (Court of Claims, 1988)